FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Theresa Whiteside

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Co-author Network

Publications

TOP 3
Malgorzata Harasymczuk; Aleksandra Kruk-Zagajewska; Witold Szyfter; Hanna Tomczak; Grzegorz Dworacki; William Gooding; Jerzy Wojtowicz; Theresa L Whiteside
Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.
Dejan Baskic; Eugene N Myers; Lazar Vujanovic; Nebojsa Arsenijevic; Theresa L Whiteside; Nikola L Vujanovic
Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer.
Malgorzata Czystowska; Robert L Ferris; William Gooding; Jonas T Johnson; Andres Lopez-Abaitero; Miroslaw J Szczepanski; Theresa L Whiteside
The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Theresa Whiteside (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Malgorzata Harasymczuk; Aleksandra Kruk-Zagajewska; Witold Szyfter; Hanna Tomczak; Grzegorz Dworacki; William Gooding; Jerzy Wojtowicz; Theresa L Whiteside
Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2013;270(3):1105-14.
2013: Dejan Baskic; Eugene N Myers; Lazar Vujanovic; Nebojsa Arsenijevic; Theresa L Whiteside; Nikola L Vujanovic
Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer.
Head & neck 2013;35(3):388-98.
2013: Malgorzata Czystowska; Robert L Ferris; William Gooding; Jonas T Johnson; Andres Lopez-Abaitero; Miroslaw J Szczepanski; Theresa L Whiteside
The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(4):889-99.
2013: Theresa L Whiteside
Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
Biochemical Society transactions 2013;41(1):245-51.
2013: Miroslaw J Szczepanski; Mariola Zagor; Michał Łuczak; Jacek Banaszewski; Albert B DeLeo; Grzegorz Dworacki; Tomasz Kopec; Aleksandra Kruk-Zagajewska; Antoni Krzeski; Maciej Kurpisz; Jan Misiak; Marta Molinska-Glura; Natalia Rozwadowska; Bronislawa Szarzynska; Theresa L Whiteside
PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Oral oncology 2013;49(2):144-51.
2013: Bastian Schilling; Patrick Schuler; James Egan; Soldano Ferrone; Malgorzata Harasymczuk; Theresa L Whiteside
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
PloS one 2013;8(2):e47234.
2013: Theresa L Whiteside; Soldano Ferrone
IGKC and prognosis in breast cancer--response to Schmidt.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(1):305.
2012: Marta Szajnik; Miroslaw J Szczepanski; Carmen Visus; Albert B DeLeo; Esther Elishaev; Marta Glura; Diana Lenzner; Maciej Zabel; Theresa L Whiteside
17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
Gynecologic oncology 2012;127(3):587-94.
2012: Theresa L Whiteside; Patrick Schuler; Bastian Schilling
Induced and natural regulatory T cells in human cancer.
Expert opinion on biological therapy 2012;12(10):1383-97.
2012: B Schilling; P Schuler; James Egan; E S Halstead; M Harasymczuk; Theresa L Whiteside
IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
Cancer immunology, immunotherapy : CII 2012;61(9):1395-405.
2012: Carsten Schaefer; Carmen Visus; Andreas Albers; Lisa H Butterfield; Grace G Kim; John M Kirkwood; Sandra Lee; Theresa L Whiteside
Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).
International journal of cancer. Journal international du cancer 2012;131(4):874-84.
2012: Theresa L Whiteside
What are regulatory T cells (Treg) regulating in cancer and why?
Seminars in cancer biology 2012;22(4):327-34.
2012: Athanasios Kotsakis; Bastian Schilling; Athanassios Argiris; Vasilis Georgoulias; Malgorzata Harasymczuk; Theresa L Whiteside
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
Journal of immunological methods 2012;381(1-2):14-22.
2012: Patrick J Schuler; Malgorzata Harasymczuk; Thomas K Hoffmann; Jonas Johnson; Stephan Lang; Bastian Schilling; Theresa L Whiteside
Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
European journal of immunology 2012;42(7):1876-85.
2012: Theresa L Whiteside; Gregory T Wolf; Lorraine Baltzer; Lisa H Butterfield; James Egan; John W Hadden; Paul H Naylor; Neil L Berinstein
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma.
Cancer immunology, immunotherapy : CII 2012;61(6):783-8.
2012: Neil L Berinstein; Harvey J Brandwein; James Egan; Adel El-Naggar; Wolf-Herve Fridman; Lynn C Goldstein; Paul H Naylor; J Michael White; Theresa L Whiteside; Gregory T Wolf; Cecile Badoual; Lorraine Baltzer; John W Hadden
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.
Cancer immunology, immunotherapy : CII 2012;61(6):771-82.
2012: Theresa L Whiteside; Soldano Ferrone
For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(9):2417-9.
2012: Osama E Rahma; Mortada A Shams; Seth M Steinberg; Marta E Szajnik; Carmen Visus; Theresa L Whiteside; Eva Wieckowski; Judith K Wolf; Ed Ashtar; Jeffrey G Bell; Sarah Bernstein; Jay A Berzofsky; Malgorzata Czystowska; Albert B DeLeo; William Gooding; Vincent E Herrin; Maria Merino; Samir N Khleif
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
Cancer immunology, immunotherapy : CII 2012;61(3):373-84.
2012: Theresa L Whiteside
Disarming suppressor cells to improve immunotherapy.
Cancer immunology, immunotherapy : CII 2012;61(2):283-8.
2012: Bastian Schilling; Patrick Schuler; James E Egan; Malgorzata Harasymczuk; Theresa L Whiteside
IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model.
Journal of molecular medicine (Berlin, Germany) 2012;90(2):139-47.
2011: Thomas K Hoffmann; Stephan Lang; Goetz Lehnerdt; Stefan Mattheis; Kornelia Okulicz; Kathrin Scheckenbach; Patrick Schuler; Judith Arnolds; Murat Bas; Christoph Bergmann; Sven Brandau; Oliviera J Finn; Jens Greve; Sokratis Trellakis; Theresa L Whiteside; Enikö Sonkoly
Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.
Anticancer research 2011;31(10):3151-7.
2011: Carmen Visus; Yangyang Wang; Theresa L Whiteside; Randall E Brand; Albert B DeLeo; Robert L Ferris; Cristina R Ferrone; Soldano Ferrone; Antonio Lozano-Leon; Susan Silver; Miroslaw J Szczepanski; Xinhui Wang
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(19):6174-84.
2011: Miroslaw J Szczepanski; Ann Welsh; Theresa L Whiteside; Marta Szajnik; Michael Boyiadzis
Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.
Haematologica 2011;96(9):1302-9.
2011: Claudia Alexandra Dumitru; Hossein Gholaman; Xiang Gu; Stephan Lang; Sokratis Trellakis; Theresa L Whiteside; Agnes Bankfalvi; Kirsten Bruderek; Nina Dominas; Sven Brandau
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
International journal of cancer. Journal international du cancer 2011;129(4):859-69.
2011: Patrick J Schuler; Malgorzata Harasymczuk; Stephan Lang; Bastian Schilling; Theresa L Whiteside
Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.
Journal of immunological methods 2011;369(1-2):59-68.
2011: Malgorzata Czystowska; Miroslaw J Szczepanski; Marta Szajnik; Karen Quadrini; Harvey Brandwein; John W Hadden; Theresa L Whiteside
Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.
Cancer immunology, immunotherapy : CII 2011;60(4):495-506.
2011: Patrick J Schuler; V Börger; Edwin Bölke; D Habermehl; C Matuschek; C A Wild; J Greve; Murat Bas; B Schilling; C Bergmann; Sokratis Trellakis; Wilfried Budach; Thomas Gauler; S Brandau; Stephan Lang; Theresa L Whiteside; Rüdiger V Sorg; Thomas K Hoffmann
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
European journal of medical research 2011;16(2):57-62.
2011: Theresa L Whiteside; Deborah L Griffin; Joanna Stanson; William Gooding; David McKenna; Darin Sumstad; Diane Kadidlo; Adrian Gee; April Durett; Robert Lindblad; Deborah Wood; David Styers
Shipping of therapeutic somatic cell products.
Cytotherapy 2011;13(2):201-13.
2011: Patrick Schuler; Theresa L Whiteside; Stephan Lang; Goetz F Lehnerdt; Pedro A Andrade Filho; Murat Bas; Petra Boeckers; Edwin Boelke; Sven Brandau; Claudia Alexandra Dumitru; Rainer Engers; Robert L Ferris; Jens Greve; Thomas K Hoffmann
EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma.
Journal of translational medicine 2011;9():168.
2011: Theresa L Whiteside; Timothy M Clay; James L Gulley; Kwong-Yok Tsang
Immunologic monitoring of cellular immune responses in cancer vaccine therapy.
Journal of biomedicine & biotechnology 2011;2011():370374.
2011: Margaret V Ragni; Charity G Moore; K Soadwa; Michael A Nalesnik; Albert B Zajko; A Cortese-Hassett; Theresa L Whiteside; S Hart; Adriana Zeevi; Jianguo Li; Obaid S Shaikh
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(1):103-11.
2010: Magis Mandapathil; Miroslaw J Szczepanski; Marta Szajnik; Jin Ren; Edwin K Jackson; Jonas T Johnson; Elieser Gorelik; Stephan Lang; Theresa L Whiteside
Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
The Journal of biological chemistry 2010;285(36):27571-80.
2010: Theresa L Whiteside
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.
Expert opinion on biological therapy 2010;10(7):1019-35.
2010: Malgorzata Czystowska; Laura Strauss; Christoph Bergmann; Marta Szajnik; Hannah Rabinowich; Theresa L Whiteside
Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
Journal of molecular medicine (Berlin, Germany) 2010;88(6):577-88.
2010: Magis Mandapathil; Benedict Hilldorfer; Miroslaw J Szczepanski; Malgorzata Czystowska; Marta Szajnik; Jin Ren; Stephan Lang; Edwin K Jackson; Elieser Gorelik; Theresa L Whiteside
Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.
The Journal of biological chemistry 2010;285(10):7176-86.
2010: Theresa L Whiteside
Immune responses to malignancies.
The Journal of allergy and clinical immunology 2010;125(2 Suppl 2):S272-83.
2010: Marta Szajnik; Malgorzata Czystowska; Miroslaw J Szczepanski; Magis Mandapathil; Theresa L Whiteside
Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).
PloS one 2010;5(7):e11469.
2010: Bernard J C Macatangay; Marta E Szajnik; Theresa L Whiteside; Sharon A Riddler; Charles Rinaldo
Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.
PloS one 2010;5(3):e9852.
2010: Miroslaw J Szczepanski; Marta Szajnik; Ann Welsh; Kenneth A Foon; Theresa L Whiteside; Michael Boyiadzis
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
Cancer immunology, immunotherapy : CII 2010;59(1):73-9.
2009: M Szajnik; M J Szczepanski; M Czystowska; Esther Elishaev; M Mandapathil; Ewa Nowak-Markwitz; M Spaczynski; Theresa L Whiteside
TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
Oncogene 2009;28(49):4353-63.
2009: Lisheng Ge; Dejan Baskic; Per H Basse; Lazar Vujanovic; Sebnem Unlu; Toshie Yoneyama; Andrea Vujanovic; Jie Han; Dragic Bankovic; Miroslaw J Szczepanski; Jennifer L Hunt; Ronald B Herberman; Susanne M Gollin; Robert L Ferris; Theresa L Whiteside; Eugene N Myers; Nikola L Vujanovic
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):2913-22.
2009: Theresa L Whiteside
Tricks tumors use to escape from immune control.
Oral oncology 2009;45(10):e119-23.
2009: Eva U Wieckowski; Carmen Visus; Marta Szajnik; Miroslaw J Szczepanski; Walter J Storkus; Theresa L Whiteside
Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(6):3720-30.
2009: Kazuaki Chikamatsu; Koichi Sakakura; Goro Takahashi; Atsushi Okamoto; Nobuhiko Furuya; Theresa L Whiteside; Albert B DeLeo; Keisuke Masuyama
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
Cancer immunology, immunotherapy : CII 2009;58(9):1441-8.
2009: Magis Mandapathil; Stephan Lang; Elieser Gorelik; Theresa L Whiteside
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.
Journal of immunological methods 2009;346(1-2):55-63.
2009: Andreas Albers; Carsten Schaefer; Carmen Visus; William Gooding; Albert B DeLeo; Theresa L Whiteside
Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
Head & neck 2009;31(6):773-81.
2009: Thomas K Hoffmann; Kerstin Schirlau; Eniko Sonkoly; Sven Brandau; Stephan Lang; Andor Pivarcsi; Vera Balz; Anja Müller; Bernhard Homey; Edwin Boelke; Torsten Reichert; Ulrike Friebe-Hoffmann; Jens Greve; Patrick Schuler; Kathrin Scheckenbach; Jörg Schipper; Murat Bas; Theresa L Whiteside; Henning Bier
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.
International journal of cancer. Journal international du cancer 2009;124(11):2589-96.
2009: Miroslaw J Szczepanski; Marta Szajnik; Malgorzata Czystowska; Magis Mandapathil; Laura Strauss; Ann Welsh; Kenneth A Foon; Theresa L Whiteside; Michael Boyiadzis
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3325-32.
2009: M Czystowska; J Han; M J Szczepanski; M Szajnik; K Quadrini; H Brandwein; J W Hadden; K Signorelli; Theresa L Whiteside
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.
Cell death and differentiation 2009;16(5):708-18.
2009: Miroslaw J Szczepanski; Malgorzata Czystowska; Marta Szajnik; Malgorzata Harasymczuk; Michael Boyiadzis; Aleksandra Kruk-Zagajewska; Witold Szyfter; Jan Zeromski; Theresa L Whiteside
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
Cancer research 2009;69(7):3105-13.
2009: Christoph Bergmann; Laura Strauss; Eva Wieckowski; Malgorzata Czystowska; Andreas Albers; Yun Wang; Reinhard Zeidler; Stephan Lang; Theresa L Whiteside
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.
Head & neck 2009;31(3):371-80.
2009: Laura Strauss; Christoph Bergmann; Theresa L Whiteside
Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(3):1469-80.
2009: Theresa L Whiteside; Paolo Piazza; Amanda Reiter; Joanna Stanson; Nancy C Connolly; Charles Rinaldo; Sharon A Riddler
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
Clinical and vaccine immunology : CVI 2009;16(2):233-40.
2009: Laura Strauss; Malgorzata Czystowska; Marta Szajnik; Magis Mandapathil; Theresa L Whiteside
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
PloS one 2009;4(6):e5994.
2009: Lazar Vujanovic; Theresa L Whiteside; Douglas M Potter; Jessica Chu; Soldano Ferrone; Lisa H Butterfield
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.
Cancer immunology, immunotherapy : CII 2009;58(1):121-33.
2008: Thomas K Hoffmann; Eniko Sonkoly; Ulrich Hauser; Anke van Lierop; Theresa L Whiteside; Jens Peter Klussmann; Dieter Hafner; Patrick Schuler; Ulrike Friebe-Hoffmann; Kathrin Scheckenbach; Kaisa Erjala; Reidar Grénman; Jörg Schipper; Henning Bier; Vera Balz
Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
Oral oncology 2008;44(12):1100-9.
2008: Theresa L Whiteside
The tumor microenvironment and its role in promoting tumor growth.
Oncogene 2008;27(45):5904-12.
2008: Albert B DeLeo; Theresa L Whiteside
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
Expert review of vaccines 2008;7(7):1031-40.
2008: Kazuaki Chikamatsu; Koichi Sakakura; Takanori Yamamoto; Nobuhiko Furuya; Theresa L Whiteside; Keisuke Masuyama
CD4+ T helper responses in squamous cell carcinoma of the head and neck.
Oral oncology 2008;44(9):870-7.
2008: Christoph Bergmann; Laura Strauss; Yun Wang; Miroslaw J Szczepanski; Stephan Lang; Jonas T Johnson; Theresa L Whiteside
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3706-15.
2008: Laura Strauss; Christoph Bergmann; Miroslaw J Szczepanski; Stephan Lang; John M Kirkwood; Theresa L Whiteside
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):2967-80.
2008: Nancy C Connolly; Theresa L Whiteside; Cara Wilson; Venkatswarlu Kondragunta; Charles Rinaldo; Sharon A Riddler
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
Clinical and vaccine immunology : CVI 2008;15(2):284-92.
2008: Theresa L Whiteside
Immune monitoring of clinical trials with biotherapies.
Advances in clinical chemistry 2008;45():75-97.
2008: Lisa H Butterfield; William Gooding; Theresa L Whiteside
Development of a potency assay for human dendritic cells: IL-12p70 production.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):89-100.
2007: Laura Strauss; Christoph Bergmann; Theresa L Whiteside
Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
International journal of cancer. Journal international du cancer 2007;121(11):2473-83.
2007: Theresa L Whiteside
Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor.
Current cancer drug targets 2007;7(7):633-42.
2007: Laura Strauss; Christoph Bergmann; William Gooding; Jonas T Johnson; Theresa L Whiteside
The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6301-11.
2007: Carmen Visus; Diasuke Ito; Andrew A Amoscato; Malgorzata Maciejewska-Franczak; Ahmed Abdelsalem; Rajiv Dhir; Dong M Shin; Vera S Donnenberg; Theresa L Whiteside; Albert B DeLeo
Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
Cancer research 2007;67(21):10538-45.
2007: Soldano Ferrone; Theresa L Whiteside
Tumor microenvironment and immune escape.
Surgical oncology clinics of North America 2007;16(4):755-74, viii.
2007: Christoph Bergmann; Laura Strauss; Reinhard Zeidler; Stephan Lang; Theresa L Whiteside
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Cancer research 2007;67(18):8865-73.
2007: Christoph Bergmann; Laura Strauss; Reinhard Zeidler; Stephan Lang; Theresa L Whiteside
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Cancer immunology, immunotherapy : CII 2007;56(9):1429-42.
2007: Grace G Kim; Vera S Donnenberg; Albert D Donnenberg; William Gooding; Theresa L Whiteside
A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Journal of immunological methods 2007;325(1-2):51-66.
2007: Nancy C Connolly; Sharon A Riddler; Joanna Stanson; William Gooding; Charles Rinaldo; Soldano Ferrone; Theresa L Whiteside
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects.
AIDS (London, England) 2007;21(13):1683-92.
2007: Laura Strauss; Christoph Bergmann; Miroslaw Szczepanski; William Gooding; Jonas T Johnson; Theresa L Whiteside
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4345-54.
2007: Daisuke Ito; Carmen Visus; Thomas K Hoffmann; Vera Balz; Henning Bier; Ettore Appella; Theresa L Whiteside; Robert L Ferris; Albert B DeLeo
Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 2007;120(12):2618-24.
2007: Thomas K Hoffmann; Eniko Sonkoly; Bernhard Homey; Kathrin Scheckenbach; Christian Gwosdz; Murat Bas; Adam Chaker; Kerstin Schirlau; Theresa L Whiteside
Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
Head & neck 2007;29(5):472-8.
2007: Charles J Lin; Jennifer Rubin Grandis; Thomas Carey; Susanne M Gollin; Theresa L Whiteside; Wayne M Koch; Robert L Ferris; Stephen Y Lai
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.
Head & neck 2007;29(2):163-88.
2007: Jill M Cyranowski; Anna L Marsland; Joyce T Bromberger; Theresa L Whiteside; Yuefang Chang; Karen A Matthews
Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro.
Brain, behavior, and immunity 2007;21(2):229-37.
2007: Ryo Ueda; Keri L Low; Xinmei Zhu; Mitsugu Fujita; Kotaro Sasaki; Theresa L Whiteside; Lisa H Butterfield; Hideho Okada
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.
Journal of translational medicine 2007;5():68.
2007: Hideho Okada; Frank S Lieberman; Kevin A Walter; L Dade Lunsford; Douglas S Kondziolka; Ghassan K Bejjani; Ronald L Hamilton; Alejandro Torres-Trejo; Pawel Kalinski; Quan Cai; Jennifer L Mabold; Howard D Edington; Lisa H Butterfield; Theresa L Whiteside; Douglas M Potter; S Clifford Schold; Ian F Pollack
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.
Journal of translational medicine 2007;5():67.
2007: Theresa L Whiteside
The role of death receptor ligands in shaping tumor microenvironment.
Immunological investigations 2007;36(1):25-46.
2007: Eva Wieckowski; Yoshinari Atarashi; Joanna Stanson; Taka-Aki Sato; Theresa L Whiteside
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Journal of cellular biochemistry 2007;100(1):16-28.
2006: Elisa Artusio; Bridget Hathaway; Joanna Stanson; Theresa L Whiteside
Transfection of human monocyte-derived dendritic cells with native tumor DNA induces antigen-specific T-cell responses in vitro.
Cancer biology & therapy 2006;5(12):1624-31.
2006: Daisuke Ito; Andreas Albers; Yong Xiang Zhao; Carmen Visus; Ettore Appella; Theresa L Whiteside; Albert B DeLeo
The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6795-803.
2006: Murat Bas; Henning Bier; Kerstin Schirlau; Ulrike Friebe-Hoffmann; Kathrin Scheckenbach; Vera Balz; Theresa L Whiteside; Thomas K Hoffmann
Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Oral oncology 2006;42(7):691-7.
2006: Robert L Ferris; Theresa L Whiteside; Soldano Ferrone
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3890-5.
2006: Anja Muller; Eniko Sonkoly; Christine Eulert; Peter Arne Gerber; Robert Kubitza; Kerstin Schirlau; Petra Franken-Kunkel; Christopher Poremba; Carl Snyderman; Lars-Oliver Klotz; Thomas Ruzicka; Henning Bier; Albert Zlotnik; Theresa L Whiteside; Bernhard Homey; Thomas K Hoffmann
Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy.
International journal of cancer. Journal international du cancer 2006;118(9):2147-57.
2006: Andreas Albers; Carmen Visus; Takashi Tsukishiro; Robert L Ferris; William Gooding; Theresa L Whiteside; Albert B De Leo
Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2394-403.
2006: Thomas K Hoffmann; Christian Arsov; Kerstin Schirlau; Murat Bas; Ulrike Friebe-Hoffmann; Jens Peter Klussmann; Kathrin Scheckenbach; Vera Balz; Henning Bier; Theresa L Whiteside
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx.
International journal of cancer. Journal international du cancer 2006;118(8):1984-91.
2006: Alan J Rosenbloom; R L Ferris; R Ferris; David M Sipe; Sharon A Riddler; Nancy C Connolly; K Abe; Theresa L Whiteside
In vitro and in vivo protein sampling by combined microdialysis and ultrafiltration.
Journal of immunological methods 2006;309(1-2):55-68.
2006: Theresa L Whiteside
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
Seminars in cancer biology 2006;16(1):3-15.
2006: Eva Wieckowski; Theresa L Whiteside
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles.
Immunologic research 2006;36(1-3):247-54.
2006: Theresa L Whiteside
The role of immune cells in the tumor microenvironment.
Cancer treatment and research 2006;130():103-24.
2005: Andreas Albers; Koji Abe; Jennifer Hunt; Jun Wang; Andres Lopez-Albaitero; Carsten Schaefer; William Gooding; Theresa L Whiteside; Soldano Ferrone; Albert B DeLeo; Robert L Ferris
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Cancer research 2005;65(23):11146-55.
2005: Jeong-Whun Kim; Robert L Ferris; Theresa L Whiteside
Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7901-10.
2005: Andreas Albers; Robert L Ferris; Grace G Kim; Kazuaki Chikamatsu; Albert B DeLeo; Theresa L Whiteside
Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
Cancer immunology, immunotherapy : CII 2005;54(11):1072-81.
2005: Theresa L Whiteside
Lymphocyte homeostasis and the antitumor immune response.
Expert review of clinical immunology 2005;1(3):369-78.
2005: Irina L Tourkova; Galina V Shurin; Gurkamal S Chatta; Lori Perez; James Finke; Theresa L Whiteside; Soldano Ferrone; Michael R Shurin
Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):3045-52.
2005: Iris Kuss; Carsten Schaefer; Tony E Godfrey; Robert L Ferris; Jeffrey M Harris; William Gooding; Theresa L Whiteside
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.
Clinical immunology (Orlando, Fla.) 2005;116(1):27-36.
2005: Christopher H Evans; Paul D Robbins; Steven C Ghivizzani; Mary Chester Wasko; Matthew M Tomaino; Richard Kang; Thomas A Muzzonigro; Molly Vogt; Elaine Elder; Theresa L Whiteside; simon simon watkins; James H Herndon
Gene transfer to human joints: progress toward a gene therapy of arthritis.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(24):8698-703.
2005: Carsten Schaefer; Grace G Kim; Andreas Albers; K Hoermann; E N Myers; Theresa L Whiteside
Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer.
British journal of cancer 2005;92(5):913-20.
2005: Bridget Hathaway; Douglas Landsittel; William Gooding; Theresa L Whiteside; Jennifer Rubin Grandis; Jill M Siegfried; William L Bigbee; Robert L Ferris
Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients.
The Laryngoscope 2005;115(3):522-7.
2005: Michael T Lotze; Ena Wang; Francesco M Marincola; Nabil Hanna; Peter J Bugelski; Christine A Burns; George Coukos; Nitin Damle; Tony E Godfrey; W Martin Howell; Monica C Panelli; Michael A Perricone; Emanuel F Petricoin; Guido Sauter; Carmen Scheibenbogen; Steve Shivers; D Lansing Taylor; John N Weinstein; Theresa L Whiteside
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(2):79-119.
2005: Jeong-Whun Kim; Eva Wieckowski; Douglas D Taylor; Torsten E Reichert; simon simon watkins; Theresa L Whiteside
Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1010-20.
2005: Theresa L Whiteside
Immunobiology of head and neck cancer.
Cancer metastasis reviews 2005;24(1):95-105.
2005: Iris Kuss; Bridget Hathaway; Robert L Ferris; William Gooding; Theresa L Whiteside
Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Advances in oto-rhino-laryngology 2005;62():161-72.
2005: Thomas K Hoffmann; Henning Bier; Albert D Donnenberg; Theresa L Whiteside; Albert B De Leo
p53 as an immunotherapeutic target in head and neck cancer.
Advances in oto-rhino-laryngology 2005;62():151-60.
2004: Shen Li; Jun Xu; Valeria P Makarenkova; Tjendimin Tjandrawan; Jukka Vakkila; Torsten E Reichert; William Gooding; Carl F Lagenaur; Cristian L Achim; William Chambers; Ronald Herberman; Theresa L Whiteside; Nikola L Vujanovic
A novel epitope of N-CAM defines precursors of human adherent NK cells.
Journal of leukocyte biology 2004;76(6):1187-99.
2004: Thomas K Hoffmann; Henning Bier; Theresa L Whiteside
Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
Cancer immunology, immunotherapy : CII 2004;53(12):1055-67.
2004: Nicky Sirianni; Patrick K Ha; Mathias Oelke; Joseph A Califano; William Gooding; William H Westra; Theresa L Whiteside; Wayne M Koch; Jonathan P Schneck; Albert B DeLeo; Robert L Ferris
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6929-37.
2004: Theresa L Whiteside
Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?
Cancer immunology, immunotherapy : CII 2004;53(10):865-78.
2004: Jeong-Whun Kim; Takashi Tsukishiro; Jonas T Johnson; Theresa L Whiteside
Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5101-10.
2004: Theresa L Whiteside; Joanna Stanson; Michael R Shurin; Soldano Ferrone
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1526-34.
2004: Iris Kuss; Bridget Hathaway; Robert L Ferris; William Gooding; Theresa L Whiteside
Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3755-62.
2004: Jun Wang; Liqiang Xi; Jennifer L Hunt; William Gooding; Theresa L Whiteside; Zhuo Chen; Tony E Godfrey; Robert L Ferris
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.
Cancer research 2004;64(5):1861-6.
2004: Theresa L Whiteside; Christine Odoux
Dendritic cell biology and cancer therapy.
Cancer immunology, immunotherapy : CII 2004;53(3):240-8.
2003: Takashi Tsukishiro; Albert D Donnenberg; Theresa L Whiteside
Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Cancer immunology, immunotherapy : CII 2003;52(10):599-607.
2003: Hideho Okada; Frank S Lieberman; Howard D Edington; Timothy F Witham; Mark J Wargo; Quan Cai; Elaine H Elder; Theresa L Whiteside; S Clifford Schold; Ian F Pollack
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.
Journal of neuro-oncology 2003;64(1-2):13-20.
2003: Theresa L Whiteside; William Gooding
Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma.
Blood cells, molecules & diseases 2003;31(1):63-71.
2003: Kazuaki Chikamatsu; Andreas Albers; Joanna Stanson; William W Kwok; Ettore Appella; Theresa L Whiteside; Albert B DeLeo
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.
Cancer research 2003;63(13):3675-81.
2003: Thomas Bauernhofer; Iris Kuss; Ulrike Friebe-Hoffmann; A S Baum; Grzegorz Dworacki; B K Vonderhaar; Theresa L Whiteside
Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.
British journal of cancer 2003;88(8):1301-9.
2003: Li-Fang Zhang; Wei-Min Gao; Robert Gealy; Joel L Weissfeld; Elaine Elder; Theresa L Whiteside; Phouthone Keohavong
Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2003;8(2):156-61.
2003: Theresa L Whiteside
22. Immune responses to malignancies.
The Journal of allergy and clinical immunology 2003;111(2 Suppl):S677-86.
2003: Theresa L Whiteside; Yongxiang Zhao; Takashi Tsukishiro; Elaine Elder; William Gooding; Joseph Baar
Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):641-9.
2003: Iris Kuss; Albert D Donnenberg; William Gooding; Theresa L Whiteside
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
British journal of cancer 2003;88(2):223-30.
2003: Thomas Bauernhofer; Iris Kuss; Brent Henderson; Andrew S Baum; Theresa L Whiteside
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
European journal of immunology 2003;33(1):119-24.
2002: Theresa L Whiteside
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy.
Vaccine 2002;20 Suppl 4():A46-51.
2002: Iris Kuss; Hannah Rabinowich; William Gooding; Robert Edwards; Theresa L Whiteside
Expression of zeta in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):631-40.
2002: Theresa L Whiteside
Cytokine assays.
BioTechniques 2002;Suppl():4-8, 10, 12-5.
2002: John M Kirkwood; Thomas Richards; Hassane M Zarour; Jeffrey A Sosman; Marc S Ernstoff; Theresa L Whiteside; Joseph G Ibrahim; Ronald Blum; Samuel Wieand; Ruth Mascari
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
Cancer 2002;95(5):1101-12.
2002: Thomas K Hoffmann; Grzegorz Dworacki; Takashi Tsukihiro; Norbert Meidenbauer; William Gooding; Jonas T Johnson; Theresa L Whiteside
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2553-62.
2002: Susanne Beckebaum; Vito R Cicinnati; Grzegorz Dworacki; Jan Muller-Berghaus; Donna Stolz; Jo Harnaha; Theresa L Whiteside; Angus W Thomson; Lina Lu; John J Fung; C Andrew Bonham
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection.
Clinical immunology (Orlando, Fla.) 2002;104(2):138-50.
2002: Theresa L Whiteside; Andrea Gambotto; Andreas Albers; Joanna Stanson; Edward P Cohen
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(14):9415-20.
2002: Thomas K Hoffmann; Albert D Donnenberg; Sydney D Finkelstein; Vera S Donnenberg; Ulrike Friebe-Hoffmann; Eugene N Myers; Ettore Appella; Albert B DeLeo; Theresa L Whiteside
Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Cancer research 2002;62(12):3521-9.
2002: Thomas K Hoffmann; Jan Muller-Berghaus; Robert L Ferris; Jonas T Johnson; Walter J Storkus; Theresa L Whiteside
Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1787-93.
2002: Per H Basse; Theresa L Whiteside; Ronald Herberman
Cancer immunotherapy with interleukin-2-activated natural killer cells.
Molecular biotechnology 2002;21(2):161-70.
2002: Tadao Asai; Walter J Storkus; Jan Muller-Berghaus; William Knapp; Albert B DeLeo; Kazuaki Chikamatsu; Theresa L Whiteside
In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins.
Cancer immunity 2002;2():3.
2002: Jaafar Bennouna; Allan Hildesheim; Kazuaki Chikamatsu; William Gooding; Walter J Storkus; Theresa L Whiteside
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses.
Journal of immunological methods 2002;261(1-2):145-56.
2002: Ganwei Lu; Bratislav Janjic; Jelena M Janjic; Theresa L Whiteside; Walter J Storkus; Nikola L Vujanovic
Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1831-9.
2002: Bratislav Janjic; Ganwei Lu; Alexei Pimenov; Theresa L Whiteside; Walter J Storkus; Nikola L Vujanovic
Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1823-30.
2002: Theresa L Whiteside
Tumor-induced death of immune cells: its mechanisms and consequences.
Seminars in cancer biology 2002;12(1):43-50.
2002: Thomas K Hoffmann; Douglas J Loftus; Koji Nakano; Markus J Maeurer; Kazuaki Chikamatsu; Ettore Appella; Theresa L Whiteside; Albert B DeLeo
The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1338-47.
2002: Norbert Meidenbauer; William Gooding; LE Spitler; D Harris; Theresa L Whiteside
Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer.
British journal of cancer 2002;86(2):168-78.
2001: H Kao; Jarrod A Marto; Thomas K Hoffmann; Jeffrey Shabanowitz; Sydney D Finkelstein; Theresa L Whiteside; Donald F Hunt; Olivera J Finn
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.
The Journal of experimental medicine 2001;194(9):1313-23.
2001: Theresa L Whiteside
Isolation of human NK cells and generation of LAK activity.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 7():Unit 7.7.
2001: Theresa L Whiteside
Measurement of cytotoxic activity of NK/LAK cells.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 7():Unit 7.18.
2001: Hideho Okada; Ian F Pollack; Frank S Lieberman; L Dade Lunsford; Douglas Kondziolka; David Schiff; Jason Attanucci; Howard D Edington; William Chambers; Pawel Kalinski; D Kinzler; Theresa L Whiteside; Elaine Elder; D Potter
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.
Human gene therapy 2001;12(5):575-95.
2001: Grzegorz Dworacki; Norbert Meidenbauer; Iris Kuss; Thomas K Hoffmann; William Gooding; M Lotze; Theresa L Whiteside
Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):947s-957s.
2001: Thomas K Hoffmann; Norbert Meidenbauer; Jan Muller-Berghaus; Walter J Storkus; Theresa L Whiteside
Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(2):162-71.
2001: Theresa L Whiteside
Immunobiology and immunotherapy of head and neck cancer.
Current oncology reports 2001;3(1):46-55.
2000: Thomas K Hoffmann; Vera S Donnenberg; Ulrike Friebe-Hoffmann; EM Meyer; Charles Rinaldo; Albert B DeLeo; Theresa L Whiteside; Albert D Donnenberg
Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
Cytometry 2000;41(4):321-8.
2000: Thomas K Hoffmann; Koji Nakano; Elaine Elder; Grzegorz Dworacki; Sydney D Finkelstein; Ettore Appella; Theresa L Whiteside; Albert B DeLeo
Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5938-44.
2000: Thomas K Hoffmann; Norbert Meidenbauer; Grzegorz Dworacki; H Kanaya; Theresa L Whiteside
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
Cancer research 2000;60(13):3542-9.
2000: John M Kirkwood; Ruth Mascari; Howard D Edington; M S Rabkin; Roger S Day; Theresa L Whiteside; Daniel Vlock; Janice Shipe-Spotloe
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
Cancer 2000;88(12):2693-702.
2000: Theresa L Whiteside
Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense.
Immunological investigations 2000;29(2):149-62.
2000: Elena Ranieri; Lisa S Kierstead; Hassane M Zarour; John M Kirkwood; Michael T Lotze; Theresa L Whiteside; Walter J Storkus
Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading.
Immunological investigations 2000;29(2):121-5.
2000: S Lang; Yoshinari Atarashi; Y Nishioka; Joanna Stanson; Norbert Meidenbauer; Theresa L Whiteside
B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
Cellular immunology 2000;201(2):132-43.
2000: Theresa L Whiteside
Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.
Clinical and diagnostic laboratory immunology 2000;7(3):327-32.
2000: Norbert Meidenbauer; D T Harris; LE Spitler; Theresa L Whiteside
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer.
The Prostate 2000;43(2):88-100.
2000: T Saito; Grzegorz Dworacki; William Gooding; Michael T Lotze; Theresa L Whiteside
Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1351-64.
2000: BRIAN GASTMAN; Daniel E Johnson; Theresa L Whiteside; Hannah Rabinowich
Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events.
Blood 2000;95(6):2015-23.
2000: Ronald Herberman; Theresa L Whiteside
Summary of the International Cancer Microenvironment from meeting in Pittsburgh, Pennsylvania on October 3-6, 1999.
Cancer research 2000;60(5):1465-9.
2000: Hideho Okada; Ian F Pollack; Michael T Lotze; L Dade Lunsford; Douglas Kondziolka; Frank S Lieberman; David Schiff; Jason Attanucci; Howard D Edington; William Chambers; Paul Robbins; Joseph Baar; D Kinzler; Theresa L Whiteside; Elaine Elder
Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
Human gene therapy 2000;11(4):637-53.
2000: T Asai; Walter J Storkus; Theresa L Whiteside
Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines.
Clinical and diagnostic laboratory immunology 2000;7(2):145-54.
2000: Yoshinori Suminami; S Nagashima; Nikola L Vujanovic; Kei Hirabayashi; H Kato; Theresa L Whiteside
Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.
British journal of cancer 2000;82(4):981-9.
2000: Michael T Lotze; Michael R Shurin; Clemens Esche; Hideaki Tahara; Walter J Storkus; John M Kirkwood; Theresa L Whiteside; Elaine Elder; H Okada; Paul D Robbins
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.
The cancer journal from Scientific American 2000;6 Suppl 1():S61-6.
2000: Torsten E Reichert; S Nagashima; Y Kashii; Joanna Stanson; G Gao; Qingping Dou; Theresa L Whiteside
Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Oncogene 2000;19(4):514-25.
2000: MM deMagalhaes-Silverman; Albert D Donnenberg; Barry C Lembersky; Elaine Elder; John Lister; WB Rybka; Theresa L Whiteside; E Ball
Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):154-60.
1999: Ofer Shpilberg; J Wilson; Theresa L Whiteside; Ronald Herberman
Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
Leukemia & lymphoma 1999;36(1-2):109-21.
1999: Y Kashii; R Giorda; Ronald Herberman; Theresa L Whiteside; Nikola L Vujanovic
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5358-66.
1999: Torsten E Reichert; Y Kashii; Joanna Stanson; A Zeevi; Theresa L Whiteside
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.
British journal of cancer 1999;81(5):822-31.
1999: BRIAN GASTMAN; Y Atarshi; Torsten E Reichert; T Saito; Levent Balkir; Hannah Rabinowich; Theresa L Whiteside
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
Cancer research 1999;59(20):5356-64.
1999: Theresa L Whiteside
Signaling defects in T lymphocytes of patients with malignancy.
Cancer immunology, immunotherapy : CII 1999;48(7):346-52.
1999: Kazuaki Chikamatsu; Torsten E Reichert; Y Kashii; T Saito; S Kawashiri; E Yamamoto; Theresa L Whiteside
Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice.
International journal of cancer. Journal international du cancer 1999;82(4):532-7.
1999: A J Rosenbloom; Michael R Pinsky; C Napolitano; TS Nguyen; D Levann; N Pencosky; Adrienne Dorrance; B K Ray; Theresa L Whiteside
Suppression of cytokine-mediated beta2-integrin activation on circulating neutrophils in critically ill patients.
Journal of leukocyte biology 1999;66(1):83-9.
1999: Kazuaki Chikamatsu; Koji Nakano; Walter J Storkus; Ettore Appella; Michael T Lotze; Theresa L Whiteside; Albert B DeLeo
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1281-8.
1999: T Saito; Iris Kuss; Grzegorz Dworacki; William Gooding; Jonas T Johnson; Theresa L Whiteside
Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1263-73.
1999: BRIAN GASTMAN; Daniel E Johnson; Theresa L Whiteside; Hannah Rabinowich
Caspase-mediated degradation of T-cell receptor zeta-chain.
Cancer research 1999;59(7):1422-7.
1999: Michael A Nalesnik; Adriana Zeevi; Parmjeet S Randhawa; A Faro; Kathy J Spichty; Anthony J Demetris; John J Fung; Theresa L Whiteside; Thomas E Starzl
Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.
Clinical transplantation 1999;13(1 Pt 1):39-44.
1999: Iris Kuss; T Saito; Jonas T Johnson; Theresa L Whiteside
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):329-34.
1998: Theodore F Logan; B Banner; Uma Rao; Marc S Ernstoff; N Wolmark; Theresa L Whiteside; LM Miketic; John M Kirkwood
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy.
Clinical and experimental immunology 1998;114(3):347-54.
1998: Theresa L Whiteside; D Friberg
Natural killer cells and natural killer cell activity in chronic fatigue syndrome.
The American journal of medicine 1998;105(3A):27S-34S.
1998: Klaus J Walgenbach; Peter Heeckt; Jörg C Kalff; Joanna Stanson; Theresa L Whiteside; Andreas Hirner; Anthony Bauer
Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation.
Transplantation proceedings 1998;30(6):2600.
1998: Haifan Zhang; Samuel A Yousem; Wilbur A Franklin; Elaine Elder; Rodney J Landreneau; Peter F Ferson; Robert Keenan; Theresa L Whiteside; Mark L Levitt
Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study.
Human pathology 1998;29(9):965-71.
1998: Torsten E Reichert; Hannah Rabinowich; J T Johnson; Theresa L Whiteside
Mechanisms responsible for signaling and functional defects.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(4):295-306.
1998: Theresa L Whiteside; Hannah Rabinowich
The role of Fas/FasL in immunosuppression induced by human tumors.
Cancer immunology, immunotherapy : CII 1998;46(4):175-84.
1998: Hannah Rabinowich; Torsten E Reichert; Y Kashii; BRIAN GASTMAN; Maria C Bell; Theresa L Whiteside
Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
The Journal of clinical investigation 1998;101(11):2579-88.
1998: S Nagashima; Robbie B Mailliard; Y Kashii; Torsten E Reichert; Ronald Herberman; P Robbins; Theresa L Whiteside
Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
Blood 1998;91(10):3850-61.
1998: Theresa L Whiteside; M W Sung; S Nagashima; Kazuaki Chikamatsu; Kaori Okada; Nikola L Vujanovic
Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1135-45.
1998: Torsten E Reichert; S Watkins; Joanna Stanson; J T Johnson; Theresa L Whiteside
Endogenous IL-2 in cancer cells: a marker of cellular proliferation.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1998;46(5):603-11.
1998: Yoshinori Suminami; Y Kashii; John C Law; W C Lin; Joanna Stanson; Torsten E Reichert; Hannah Rabinowich; Theresa L Whiteside
Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells.
Oncogene 1998;16(10):1309-17.
1998: Parmjeet S Randhawa; Theresa L Whiteside; Adriana Zeevi; Elaine Elder; Abdul S Rao; Anthony J Demetris; X Weng; Luis A Valdivia; Jorge Rakela; Michael A Nalesnik
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease.
Transplantation 1998;65(2):264-8.
1998: Theresa L Whiteside
Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.
Advances in experimental medicine and biology 1998;451():167-71.
1998: Theresa L Whiteside; Nikola L Vujanovic; Ronald Herberman
Natural killer cells and tumor therapy.
Current topics in microbiology and immunology 1998;230():221-44.
1997: Michael T Lotze; B Hellerstedt; L Stolinski; T Tueting; C Wilson; D Kinzler; H Vu; Joshua Rubin; Walter J Storkus; Hideaki Tahara; Elaine Elder; Theresa L Whiteside
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.
The cancer journal from Scientific American 1997;3 Suppl 1():S109-14.
1997: Matthew F Muldoon; Janine D Flory; Anna L Marsland; Stephen B Manuck; Theresa L Whiteside; Bruce S Rabin
Effects of lovastatin on the immune system.
The American journal of cardiology 1997;80(10):1391-4.
1997: Parmjeet Randhawa; Theresa L Whiteside; Adriana Zeevi; Michael A Nalesnik; C Alvares; S M Gollin; Jake Demetris; Joseph Locker
In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.
In vitro cellular & developmental biology. Animal 1997;33(10):803-8.
1997: S Nagashima; Torsten E Reichert; Y Kashii; Yoshinori Suminami; Kazuaki Chikamatsu; Theresa L Whiteside
In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Cancer gene therapy 1997;4(6):366-76.
1997: Theodore F Logan; William Gooding; Theresa L Whiteside; Marc S Ernstoff; Sandra S Kaplan; LM Miketic; Daniel Vlock; C Tompkins; D L Wood; P I Nadler; John M Kirkwood
Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(5):387-98.
1997: Matthew F Muldoon; Anna L Marsland; Janine D Flory; Bruce S Rabin; Theresa L Whiteside; Stephen B Manuck
Immune system differences in men with hypo- or hypercholesterolemia.
Clinical immunology and immunopathology 1997;84(2):145-9.
1997: S Nagashima; Y Kashii; Torsten E Reichert; Yoshinori Suminami; T Suzuki; Theresa L Whiteside
Human gastric carcinoma transduced with the IL-2 gene: increased sensitivity to immune effector cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 1997;72(1):174-83.
1997: D Zhu; Phouthone Keohavong; Sydney D Finkelstein; Patricia A Swalsky; Anke Bakker; Joel L Weissfeld; S Srivastava; Theresa L Whiteside
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Cancer research 1997;57(12):2485-92.
1997: Michael A Nalesnik; Abdul S Rao; H Furukawa; Si Pham; Adriana Zeevi; John J Fung; G Klein; HA Gritsch; Elaine Elder; Theresa L Whiteside; Thomas E Starzl
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.
Transplantation 1997;63(9):1200-5.
1997: J M Kirkwood; J Wilson; Theresa L Whiteside; S Donnelly; Ronald Herberman
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.
Cancer immunology, immunotherapy : CII 1997;44(3):137-49.
1997: P Lai; Hannah Rabinowich; Peggy A Crowley-Nowick; Maria C Bell; G Mantovani; Theresa L Whiteside
Alterations in expression and function of signal transducing proteins in tumor-associated T and natural killer cells in ovarian carcinoma.
Biochemical Society transactions 1997;25(2):218S.
1997: Phouthone Keohavong; D Zhu; Theresa L Whiteside; Patricia A Swalsky; A Bakker; Elaine Elder; Jill M Siegfried; S Srivastava; Sydney D Finkelstein
Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Analytical biochemistry 1997;247(2):394-403.
1997: K Okada; S Yasumura; I Muller-Fleckenstein; Bernhard Fleckenstein; S Talib; U Koldovsky; Theresa L Whiteside
Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
Cellular immunology 1997;177(1):35-48.
1997: John M Kirkwood; J Bryant; J H Schiller; M M Oken; Ernest C Borden; Theresa L Whiteside
Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(2):146-57.
1997: P von Zons; P Crowley-Nowick; D Friberg; M Bell; U Koldovsky; Theresa L Whiteside
Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
Clinical and diagnostic laboratory immunology 1997;4(2):202-7.
1997: Antonio Francavilla; Nikola L Vujanovic; Lorenzo Polimeno; A Azzarone; A Iacobellis; Albert B DeLeo; M Hagiya; Theresa L Whiteside; Thomas E Starzl
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions.
Hepatology (Baltimore, Md.) 1997;25(2):411-5.
1996: Hannah Rabinowich; Yoshinori Suminami; Torsten E Reichert; Peggy A Crowley-Nowick; M Bell; R Edwards; Theresa L Whiteside
Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma.
International journal of cancer. Journal international du cancer 1996;68(3):276-84.
1996: D R Vlock; J Andersen; L A Kalish; Jonas T Johnson; John M Kirkwood; Theresa L Whiteside; Ronald Herberman; G S Adams; M M Oken; R E Haselow
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):433-42.
1996: Hannah Rabinowich; M Manciulea; Ronald Herberman; Theresa L Whiteside
Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(9):3860-8.
1996: Michael T Lotze; L Zitvogel; R Campbell; Paul D Robbins; Elaine Elder; Catherine Haluszczak; D Martin; Theresa L Whiteside; Walter J Storkus; Hideaki Tahara
Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.
Annals of the New York Academy of Sciences 1996;795():440-54.
1996: K J Walgenbach; Peter Heeckt; Joanna Stanson; Theresa L Whiteside; Anthony Bauer
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
Transplantation proceedings 1996;28(5):2454.
1996: K J Walgenbach; Peter Heeckt; Joanna Stanson; Theresa L Whiteside; Anthony Bauer
Increased expression of transforming growth factor-beta during chronic rejection.
Transplantation proceedings 1996;28(5):2450.
1996: Hannah Rabinowich; M Manciulea; Diana Metes; A Sulica; Ronald Herberman; Seth J Corey; Theresa L Whiteside
Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1485-91.
1996: Hannah Rabinowich; M Banks; Torsten E Reichert; Theodore F Logan; John M Kirkwood; Theresa L Whiteside
Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1263-74.
1996: Nikola L Vujanovic; S Nagashima; Ronald Herberman; Theresa L Whiteside
Nonsecretory apoptotic killing by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(3):1117-26.
1996: Grace L Su; K J Walgenbach; P H Heeckt; Q Wang; Willi Halfter; Theresa L Whiteside; Anthony Bauer
Increased expression of interferon-gamma in a rat model of chronic intestinal allograft rejection.
Transplantation 1996;62(2):242-8.
1996: M W Sung; S Nagashima; Jonas T Johnson; G A Van Dongen; Theresa L Whiteside
The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets.
Cellular immunology 1996;171(1):20-9.
1996: Theresa L Whiteside; Kazuaki Chikamatsu; S Nagashima; K Okada
Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Anticancer research 1996;16(4C):2357-64.
1996: Christopher H Evans; Paul D Robbins; Steven C Ghivizzani; James H Herndon; Richard Kang; Alfred B Bahnson; John A Barranger; E M Elders; S Gay; Matthew M Tomaino; Mary Chester Wasko; simon simon watkins; Theresa L Whiteside; Joseph C Glorioso; Michael T Lotze; T M Wright
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis.
Human gene therapy 1996;7(10):1261-80.
1996: J S Goydos; Elaine Elder; Theresa L Whiteside; Olivera J Finn; Michael T Lotze
A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
The Journal of surgical research 1996;63(1):298-304.
1996: A Sulica; Diana Metes; M Gherman; Theresa L Whiteside; Ronald Herberman
Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
European journal of immunology 1996;26(6):1199-203.
1996: D P Skoner; Theresa L Whiteside; J W Wilson; W J Doyle; Ronald Herberman; P Fireman
Effect of influenza A virus infection on natural and adaptive cellular immunity.
Clinical immunology and immunopathology 1996;79(3):294-302.
1996: M W Sung; Jonas T Johnson; G Van Dongen; Theresa L Whiteside
Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
International journal of cancer. Journal international du cancer 1996;66(3):393-9.
1996: L M Silla; S M Pincus; Joseph Locker; J Glover; E M Elder; A D Donnenberg; N B Nardi; J Bryant; Edward D Ball; Theresa L Whiteside
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
British journal of haematology 1996;93(2):375-85.
1996: Elaine Elder; Michael T Lotze; Theresa L Whiteside
Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer.
Human gene therapy 1996;7(4):479-87.
1996: M Manciulea; Hannah Rabinowich; A Sulica; W C Lin; Theresa L Whiteside; Albert B DeLeo; Ronald Herberman; Seth J Corey
Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells.
Cellular immunology 1996;167(1):63-71.
1996: P Lai; Hannah Rabinowich; Peggy A Crowley-Nowick; Maria C Bell; Giovanni Mantovani; Theresa L Whiteside
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):161-73.
1996: Jeffrey N Myers; S Yasumura; Yoshinori Suminami; H Hirabayashi; W c Lin; Jonas T Johnson; Michael T Lotze; Theresa L Whiteside
Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):127-35.
1995: W C Lin; S Yasumura; Yoshinori Suminami; M W Sung; S Nagashima; Joanna Stanson; Theresa L Whiteside
Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(10):4805-16.
1995: L M Silla; Theresa L Whiteside; Edward D Ball
The role of natural killer cells in the treatment of chronic myeloid leukemia.
Journal of hematotherapy 1995;4(4):269-79.
1995: A J Rosenbloom; Michael R Pinsky; J L Bryant; A Shin; T Tran; Theresa L Whiteside
Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction.
JAMA : the journal of the American Medical Association 1995;274(1):58-65.
1995: John C Law; Theresa L Whiteside; Susanne M Gollin; Joel L Weissfeld; L El-Ashmawy; S Srivastava; Rodney J Landreneau; Jonas T Johnson; Robert E Ferrell
Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(7):763-8.
1995: C Galatiuc; M Gherman; Diana Metes; A Sulica; Albert B DeLeo; Theresa L Whiteside; Ronald Herberman
Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Cellular immunology 1995;163(2):167-77.
1995: Nikola L Vujanovic; Lorenzo Polimeno; A Azzarone; Antonio Francavilla; William Chambers; Thomas E Starzl; Ronald Herberman; Theresa L Whiteside
Changes of liver-resident NK cells during liver regeneration in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(12):6324-38.
1995: M W Sung; S Yasumura; Jonas T Johnson; G A Van Dongen; Theresa L Whiteside
Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1995;61(6):864-72.
1995: John Lister; WB Rybka; Albert D Donnenberg; MM deMagalhaes-Silverman; S M Pincus; E J Bloom; E M Elder; Edward D Ball; Theresa L Whiteside
Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(6):607-14.
1995: M F Melhem; John C Law; L el-Ashmawy; Jonas T Johnson; Rodney J Landreneau; S Srivastava; Theresa L Whiteside
Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers.
The American journal of pathology 1995;146(5):1170-7.
1995: L M Silla; J Chen; R K Zhong; Theresa L Whiteside; Edward D Ball
Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
British journal of haematology 1995;89(4):712-8.
1995: Hannah Rabinowich; W C Lin; M Manciulea; Ronald Herberman; Theresa L Whiteside
Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via alpha 4 beta 1 or alpha 5 beta 1 integrins.
Blood 1995;85(7):1858-64.
1995: H Hirabayashi; S Yasumura; W C Lin; Andrew A Amoscato; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Archives of otolaryngology--head & neck surgery 1995;121(3):285-92.
1995: Hannah Rabinowich; W C Lin; Andrew A Amoscato; Ronald Herberman; Theresa L Whiteside
Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1124-35.
1995: A Sulica; William Chambers; M Manciulea; Diana Metes; Seth J Corey; Hannah Rabinowich; Theresa L Whiteside; Ronald Herberman
Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
Natural immunity 1995;14(3):123-33.
1995: Nikola L Vujanovic; S Yasumura; H Hirabayashi; W C Lin; S Watkins; Ronald Herberman; Theresa L Whiteside
Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):281-9.
1994: S Yasumura; Andrew A Amoscato; H Hirabayashi; W C Lin; Theresa L Whiteside
Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck.
Cancer immunology, immunotherapy : CII 1994;39(6):407-15.
1994: R Appasamy; J Bryant; T Hassanein; David H Van Thiel; Theresa L Whiteside
Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
Clinical immunology and immunopathology 1994;73(3):350-7.
1994: Diana Metes; C Galatiuc; I Moldovan; Penelope A Morel; William Chambers; Albert B DeLeo; Hannah Rabinowich; R Schall; Theresa L Whiteside; A Sulica
Expression and function of Fc gamma RII on human natural killer cells.
Natural immunity 1994;13(6):289-300.
1994: Hannah Rabinowich; W C Lin; Ronald Herberman; Theresa L Whiteside
Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3504-13.
1994: S Yasumura; W C Lin; E Weidmann; P Hebda; Theresa L Whiteside
Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
International journal of cancer. Journal international du cancer 1994;59(2):225-34.
1994: Carl H Snyderman; I Klapan; M Milanovich; D S Heo; R Wagner; D Schwartz; Jonas T Johnson; Theresa L Whiteside
Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1994;111(3 Pt 1):189-96.
1994: S Yasumura; W C Lin; H Hirabayashi; Nikola L Vujanovic; Ronald Herberman; Theresa L Whiteside
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
Cancer research 1994;54(14):3808-16.
1994: Theresa L Whiteside; G Parmiani
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.
Cancer immunology, immunotherapy : CII 1994;39(1):15-21.
1994: Theresa L Whiteside
Concluding comments: immunologic intervention in therapy of cancer.
Clinical immunology and immunopathology 1994;71(3):263-4.
1994: Theresa L Whiteside
Symposium-in-writing. Introduction.
Clinical immunology and immunopathology 1994;71(3):247.
1994: S Yasumura; E Weidmann; H Hirabayashi; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 1994;57(3):297-305.
1994: D Friberg; J Bryant; W Shannon; Theresa L Whiteside
In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation.
Clinical and diagnostic laboratory immunology 1994;1(3):261-8.
1994: Theresa L Whiteside
Cytokines and cytokine measurements in a clinical laboratory.
Clinical and diagnostic laboratory immunology 1994;1(3):257-60.
1994: Ronald H Goldfarb; Theresa L Whiteside; Per H Basse; W C Lin; Nikola L Vujanovic; Ronald Herberman
Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
Natural immunity 1994;13(2-3):131-40.
1994: Theresa L Whiteside; Ronald Herberman
Role of human natural killer cells in health and disease.
Clinical and diagnostic laboratory immunology 1994;1(2):125-33.
1994: Hannah Rabinowich; L Pricop; Ronald Herberman; Theresa L Whiteside
Expression and function of CD7 molecule on human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):517-26.
1994: Nikola L Vujanovic; Theresa L Whiteside
Phenotypic and functional characteristics of human A-NK cells.
Immunology series 1994;61():41-54.
1994: Theresa L Whiteside; Ronald H Goldfarb
Immunomodulation and antitumor mechanisms. Introduction.
Immunology series 1994;61():179-81.
1994: Theresa L Whiteside; Ronald H Goldfarb
Antitumor effector cells: extravasation and control of metastasis.
Immunology series 1994;61():159-73.
1994: Theresa L Whiteside
Tumor-infiltrating lymphocytes in human solid tumors.
Immunology series 1994;61():137-48.
1994: Theresa L Whiteside
Tumor microenvironment and immune effector cells. Introduction.
Immunology series 1994;61():133-6.
1994: D K McMahon; J A Armstrong; Xiao-Li Huang; Charles Rinaldo; Phalguni Gupta; Theresa L Whiteside; G J Pazin; C Tripoli; M Ho
A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine.
AIDS (London, England) 1994;8(1):59-66.
1993: Theresa L Whiteside; E Letessier; H Hirabayashi; D Vitolo; J Bryant; L Barnes; Carl H Snyderman; Jonas T Johnson; E Myers; Ronald Herberman
Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Cancer research 1993;53(23):5654-62.
1993: Hannah Rabinowich; Ronald Herberman; Theresa L Whiteside
Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
Cellular immunology 1993;152(2):481-98.
1993: W C Lin; S Yasumura; Theresa L Whiteside
Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
Archives of otolaryngology--head & neck surgery 1993;119(11):1229-35.
1993: E Weidmann; Theodore F Logan; S Yasumura; John M Kirkwood; Massimo Trucco; Theresa L Whiteside
Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Cancer research 1993;53(20):4745-9.
1993: Nikola L Vujanovic; Hannah Rabinowich; Y J Lee; L Jost; Ronald Herberman; Theresa L Whiteside
Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Cellular immunology 1993;151(1):133-57.
1993: L Pricop; Hannah Rabinowich; P A Morel; A Sulica; Theresa L Whiteside; Ronald Herberman
Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3018-29.
1993: D Torpey; Xiao-Li Huang; J Armstrong; M Ho; Theresa L Whiteside; D McMahon; G Pazin; R Heberman; Phalguni Gupta; C Tripoli
Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity.
Clinical immunology and immunopathology 1993;68(3):263-72.
1993: D Vitolo; Nikola L Vujanovic; Hannah Rabinowich; M Schlesinger; Ronald Herberman; Theresa L Whiteside
Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):1926-37.
1993: Hannah Rabinowich; P Sedlmayr; Ronald Herberman; Theresa L Whiteside
Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(11):4844-55.
1993: E Weidmann; Elaine Elder; Massimo Trucco; Michael T Lotze; Theresa L Whiteside
Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
International journal of cancer. Journal international du cancer 1993;54(3):383-90.
1993: Xiaoying Yin; Martin L Smith; Theresa L Whiteside; Jonas T Johnson; Ronald Herberman; Joseph Locker
Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1993;54(2):322-7.
1993: M Ho; J Armstrong; D McMahon; G Pazin; Xiao-Li Huang; Charles Rinaldo; Theresa L Whiteside; C Tripoli; G Levine; D Moody
A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS.
Blood 1993;81(8):2093-101.
1993: Theresa L Whiteside; Elaine Elder; D Moody; J Armstrong; M Ho; Charles Rinaldo; X Huang; D Torpey; Phalguni Gupta; D McMahon
Generation and characterization of ex vivo propagated autologous CD8+ cells used for adoptive immunotherapy of patients infected with human immunodeficiency virus.
Blood 1993;81(8):2085-92.
1993: A Sulica; C Galatiuc; M Manciulea; A C Bancu; Albert B DeLeo; Theresa L Whiteside; Ronald Herberman
Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
Cellular immunology 1993;147(2):397-410.
1993: S Yasumura; H Hirabayashi; D R Schwartz; J F Toso; J T Johnson; Ronald Herberman; Theresa L Whiteside
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Cancer research 1993;53(6):1461-8.
1993: L Vaccarello; Anisa Kanbour; Amal Kanbour-Shakir; Theresa L Whiteside
Tumor-infiltrating lymphocytes from ovarian tumors of low malignant potential.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1993;12(1):41-50.
1993: D Vitolo; Anisa Kanbour; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):371-7.
1992: T V Kantor; D Friberg; Thomas A Medsger; R B Buckingham; Theresa L Whiteside
Cytokine production and serum levels in systemic sclerosis.
Clinical immunology and immunopathology 1992;65(3):278-85.
1992: E Weidmann; M Sacchi; Stephane Plaisance; D S Heo; S Yasumura; W C Lin; Jonas T Johnson; Ronald Herberman; B Azzarone; Theresa L Whiteside
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Cancer research 1992;52(21):5963-70.
1992: E Weidmann; Theresa L Whiteside; R Giorda; Ronald Herberman; Massimo Trucco
The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Cancer research 1992;52(21):5913-20.
1992: Michael T Lotze; H J Zeh; Elaine Elder; Q Cai; B A Pippin; M M Rosenstein; Theresa L Whiteside; Ronald Herberman
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(3):212-7.
1992: Y Shimizu; Anthony J Demetris; Susanne M Gollin; P D Storto; H M Bedford; S Altarac; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
International journal of cancer. Journal international du cancer 1992;52(2):252-60.
1992: Hannah Rabinowich; D Vitolo; S Altarac; Ronald Herberman; Theresa L Whiteside
Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):340-9.
1992: D Vitolo; T Zerbe; Anisa Kanbour; C Dahl; Ronald Herberman; Theresa L Whiteside
Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):573-80.
1992: T V Kantor; Theresa L Whiteside; D Friberg; R B Buckingham; Thomas A Medsger
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
Arthritis and rheumatism 1992;35(6):694-9.
1992: K Hata; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.
Hepatology (Baltimore, Md.) 1992;15(5):816-23.
1992: L M Jost; John M Kirkwood; Theresa L Whiteside
Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells.
Journal of immunological methods 1992;147(2):153-65.
1992: Marc S Ernstoff; William Gooding; S Nair; R R Bahnson; L M Miketic; B Banner; R Day; Theresa L Whiteside; Linda Titus-Ernstoff; John M Kirkwood
Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.
Cancer research 1992;52(4):851-6.
1992: P Sedlmayr; Hannah Rabinowich; A Winkelstein; Ronald Herberman; Theresa L Whiteside
Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
British journal of cancer 1992;65(2):222-8.
1992: J Bryant; R Day; Theresa L Whiteside; Ronald Herberman
Calculation of lytic units for the expression of cell-mediated cytotoxicity.
Journal of immunological methods 1992;146(1):91-103.
1992: Theresa L Whiteside; L M Jost; Ronald Herberman
Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.
Critical reviews in oncology/hematology 1992;12(1):25-47.
1992: Theresa L Whiteside; Ronald Herberman
Extravasation of antitumor effector cells.
Invasion & metastasis 1992;12(2):128-46.
1992: Theresa L Whiteside
Tumor-infiltrating lymphocytes as antitumor effector cells.
Biotherapy (Dordrecht, Netherlands) 1992;5(1):47-61.
1992: D Vitolo; E M Letessier; Jonas T Johnson; Theresa L Whiteside
Immunologic effector cells in head and neck cancer.
Journal of the National Cancer Institute. Monographs 1992;(13):203-8.
1991: Theresa L Whiteside; J Wilson; J Bryant; Adriana Zeevi; K Abu el-Magd; Ashok Jain; Mario Alessiani; John Fung; Ronald Herberman; Thomas E Starzl
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
Transplantation proceedings 1991;23(6):3047-51.
1991: Y Shimizu; E Weidmann; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Cancer research 1991;51(22):6153-62.
1991: Theresa L Whiteside
Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
In vivo (Athens, Greece) 1991;5(6):553-9.
1991: Xiaoying Yin; M Donovan-Peluso; Theresa L Whiteside; Jonas T Johnson; R Day; Ronald Herberman; Joseph Locker
Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
Genes, chromosomes & cancer 1991;3(6):443-54.
1991: P Sedlmayr; Hannah Rabinowich; E M Elder; M S Ernstoff; J M Kirkwood; Ronald Herberman; Theresa L Whiteside
Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):336-46.
1991: K Hata; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Natural killer activity of human liver-derived lymphocytes in various liver diseases.
Hepatology (Baltimore, Md.) 1991;14(3):495-503.
1991: Carl H Snyderman; D S Heo; Jonas T Johnson; F D'Amico; Leon Barnes; Theresa L Whiteside
Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Archives of otolaryngology--head & neck surgery 1991;117(8):899-905.
1991: E M Letessier; D S Heo; T Okarma; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Cancer research 1991;51(15):3891-9.
1991: Hannah Rabinowich; P Sedlmayr; Ronald Herberman; Theresa L Whiteside
Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
Cellular immunology 1991;135(2):454-70.
1991: L Pricop; C Galatiuc; M Manciulea; Albert B DeLeo; A Sulica; Ronald Herberman; Theresa L Whiteside
Expression of Fc mu receptors on human natural killer cells.
Clinical immunology and immunopathology 1991;59(3):355-67.
1991: M Sacchi; D Vitolo; P Sedlmayr; Hannah Rabinowich; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.
International journal of cancer. Journal international du cancer 1991;47(5):784-91.
1991: M Sacchi; I Klapan; Jonas T Johnson; Theresa L Whiteside
Antiproliferative effects of cytokines on squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 1991;117(3):321-6.
1991: D R Vlock; J Johnson; E Myers; R Day; William Gooding; Theresa L Whiteside; K Pelch; B Sigler; R Wagner; D Colao
Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.
Head & neck 1991;13(1):15-21.
1991: R J Melder; E Walker; Ronald Herberman; Theresa L Whiteside
Adhesion characteristics of human interleukin 2-activated natural killer cells.
Cellular immunology 1991;132(1):177-92.
1991: Y Shimizu; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
Cancer immunology, immunotherapy : CII 1991;32(5):280-8.
1991: S M Levy; Ronald Herberman; J Lee; Theresa L Whiteside; M Beadle; L Heiden; A Simons
Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity.
Natural immunity and cell growth regulation 1991;10(6):289-307.
1990: Y K Yoo; J B Gavaler; K Chen; Theresa L Whiteside; David H Van Thiel
The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.
Clinical and experimental immunology 1990;82(2):338-43.
1990: P D Storto; S L Saidman; Anthony J Demetris; E Letessier; Theresa L Whiteside; Susanne M Gollin
Chromosomal breakpoints in cholangiocarcinoma cell lines.
Genes, chromosomes & cancer 1990;2(4):300-10.
1990: E M Letessier; M Sacchi; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Cellular immunology 1990;130(2):446-58.
1990: Marc S Ernstoff; S Nair; R R Bahnson; L M Miketic; B Banner; William Gooding; R Day; Theresa L Whiteside; T Hakala; John M Kirkwood
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1637-49.
1990: K Hata; X R Zhang; S Iwatsuki; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Isolation, phenotyping, and functional analysis of lymphocytes from human liver.
Clinical immunology and immunopathology 1990;56(3):401-19.
1990: R J Melder; Raghavan Balachandran; Charles Rinaldo; Phalguni Gupta; Theresa L Whiteside; Ronald Herberman
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
AIDS research and human retroviruses 1990;6(8):1011-5.
1990: R J Melder; E R Walker; Ronald Herberman; Theresa L Whiteside
Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
Journal of leukocyte biology 1990;48(2):163-73.
1990: D S Heo; J G Park; K Hata; R Day; Ronald Herberman; Theresa L Whiteside
Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Cancer research 1990;50(12):3681-90.
1990: L Vaccarello; Y L Wang; Theresa L Whiteside
Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2.
Human immunology 1990;28(2):216-27.
1990: M Sacchi; Carl H Snyderman; D S Heo; Jonas T Johnson; F D'Amico; Ronald Herberman; Theresa L Whiteside
Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Cancer research 1990;50(10):3113-8.
1990: M Ferrarini; V Steen; T A Medsger; Theresa L Whiteside
Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
Clinical and experimental immunology 1990;79(3):346-52.
1990: Y K Yoo; D S Heo; K Hata; David H Van Thiel; Theresa L Whiteside
Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
Gastroenterology 1990;98(2):259-68.
1990: S M Levy; Ronald Herberman; Theresa L Whiteside; K Sanzo; J Lee; J Kirkwood
Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
Psychosomatic medicine 1990;52(1):73-85.
1990: Z L Chang; Theresa L Whiteside; Ronald Herberman
Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.
Cellular immunology 1990;125(1):183-96.
1990: Theresa L Whiteside; J Bryant; R Day; Ronald Herberman
Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
Journal of clinical laboratory analysis 1990;4(2):102-14.
1990: R K Shadduck; S S Kaplan; Theresa L Whiteside; E J Wing
Biological effects of recombinant human GM-CSF.
Progress in clinical and biological research 1990;352():365-74.
1990: Theresa L Whiteside; Ronald Herberman
Serum and tissue banks for biological markers.
Immunology series 1990;53():55-68.
1990: Theresa L Whiteside; Ronald Herberman
The biology of human natural killer cells.
Annali dell'Istituto superiore di sanità 1990;26(3-4):335-48.
1990: S M Levy; Ronald Herberman; J Lee; Theresa L Whiteside; J Kirkwood; S McFeeley
Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
Natural immunity and cell growth regulation 1990;9(5):313-24.
1989: Y L Wang; S Kaplan; Theresa L Whiteside; Ronald Herberman
In vitro effects of an acyltripeptide, FK565, on antitumor effector activities and on metabolic activities of human monocytes and granulocytes.
Immunopharmacology 1989;18(3):213-22.
1989: David H Van Thiel; K N Chen; M C Chien; V J Dindzans; J S Gavaler; Theresa L Whiteside
T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis.
Digestive diseases and sciences 1989;34(11):1751-7.
1989: Y K Yoo; J S Gavaler; K N Chen; V Dindzans; D E Brouillette; Theresa L Whiteside; David H Van Thiel
Alpha-interferon. Its effect upon lymphocyte subpopulations and HLA-DR expression within the liver.
Digestive diseases and sciences 1989;34(11):1758-64.
1989: Y L Wang; L S Si; Anisa Kanbour; Ronald Herberman; Theresa L Whiteside
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
Cancer research 1989;49(21):5979-85.
1989: A Adler; V Albo; Julie Blatt; Theresa L Whiteside; Ronald Herberman
Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.
Blood 1989;74(5):1690-7.
1989: K Chen; J S Gavaler; David H Van Thiel; Theresa L Whiteside
Phenotypic characterization of mononuclear infiltrate present in liver of biliary atresia.
Digestive diseases and sciences 1989;34(10):1564-70.
1989: Theresa L Whiteside; Ronald Herberman
The role of natural killer cells in human disease.
Clinical immunology and immunopathology 1989;53(1):1-23.
1989: D S Heo; Carl H Snyderman; Susanne M Gollin; S Pan; E Walker; R Deka; E Leon Barnes; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Cancer research 1989;49(18):5167-75.
1989: R E Schwarz; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors.
Hepatology (Baltimore, Md.) 1989;10(2):221-7.
1989: Carl H Snyderman; D S Heo; K Chen; Theresa L Whiteside; Jonas T Johnson
T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer.
Head & neck 1989;11(4):331-6.
1989: M Ferrarini; D J Helfrich; E R Walker; Thomas A Medsger; Theresa L Whiteside
Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts.
The Journal of rheumatology 1989;16(6):837-41.
1989: Y L Wang; Theresa L Whiteside; D Friberg; Ronald Herberman
In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
Immunopharmacology 1989;17(3):175-85.
1989: Z L Chang; Xiao-Li Huang; Charles Rinaldo; Ronald Herberman; Theresa L Whiteside
Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages.
Clinical immunology and immunopathology 1989;51(1):133-9.
1989: Edward J Wing; D M Magee; Theresa L Whiteside; S S Kaplan; R K Shadduck
Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.
Blood 1989;73(3):643-6.
1989: R J Melder; C S Rosenfeld; Ronald Herberman; Theresa L Whiteside
Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man.
Cancer immunology, immunotherapy : CII 1989;29(1):67-73.
1989: M Tsao; M Ferrarini; C Evans; A Ambro; Theresa L Whiteside
Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells.
Clinical immunology and immunopathology 1989;50(1 Pt 1):122-31.
1989: Theresa L Whiteside; R B Buckingham
Interactions between cells of the immune system and hyaluronate synthesis by human dermal fibroblasts.
Ciba Foundation symposium 1989;143():170-81; discussion 182-6, 281-5.
1989: Theresa L Whiteside; D S Heo; S Takagi; Ronald Herberman
Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
Immunology series 1989;48():139-57.
1988: Theresa L Whiteside; Y L Wang; R G Selker; Ronald Herberman
In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
Cancer research 1988;48(21):6069-75.
1988: Theresa L Whiteside; M Ferrarini; P Hebda; R B Buckingham
Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissues.
Arthritis and rheumatism 1988;31(10):1221-9.
1988: R J Melder; Theresa L Whiteside; Nikola L Vujanovic; J C Hiserodt; Ronald Herberman
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
Cancer research 1988;48(12):3461-9.
1988: Theresa L Whiteside; S Miescher; L Moretta; V von Fliedner
Cloning and proliferating precursor frequencies of tumor-infiltrating lymphocytes from human solid tumors.
Transplantation proceedings 1988;20(2):342-3.
1988: Theresa L Whiteside; D S Heo; S Takagi; Ronald Herberman
Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
Transplantation proceedings 1988;20(2):347-50.
1988: A Adler; P A Chervenick; Theresa L Whiteside; E Lotzová; Ronald Herberman
Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.
Blood 1988;71(3):709-16.
1988: Theresa L Whiteside; D S Heo; S Takagi; Jonas T Johnson; S Iwatsuki; Ronald Herberman
Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
Cancer immunology, immunotherapy : CII 1988;26(1):1-10.
1987: D S Heo; Theresa L Whiteside; Jonas T Johnson; K N Chen; E Leon Barnes; Ronald Herberman
Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
Cancer research 1987;47(23):6353-62.
1987: Theresa L Whiteside; D S Heo; K Chen; A Adler; Jonas T Johnson; Ronald Herberman
Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Progress in clinical and biological research 1987;244():213-22.
1982: L Penchansky; Theresa L Whiteside; M R Wollman; V C Albo
Sex differences in prognosis of childhood T-cell leukemia.
Medical and pediatric oncology 1982;10(4):339-48.
1981: L Penchansky; Theresa L Whiteside; M Wollman; J Malatack
Philadelphia chromosome--positive pre-B-lymphocytic leukemia in a child.
The American journal of pediatric hematology/oncology 1981;3(3):265-8.